| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Thornberry Nancy serves as a Director at SDGR and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 4 sells. Those positions are worth an estimated $467K at current prices.
The biggest single holding is DNLI (~$467K) as Director. The recent filings there lean toward selling, a net 11,439 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | DNLI Denali Therapeutics Inc. | Director | Sell | 11,439 | $22.90 | $261,928.50 | -36.8% | - | - | |
| May 22, 2023 | SDGR Schrodinger, Inc. | Director | Sale+OE | 14,850 | $35.00 | $519,750.00 | -100% | -5.8% | -43.4% | |
| Aug 11, 2022 | SDGR Schrodinger, Inc. | Director | Sale+OE | 4,950 | $35.00 | $173,250.00 | -100% | -35.8% | +20.8% |